As the FDA approves updated Fall 2026 Covid vaccines, Columbia Pathology’s Dr. Ian Mellis weighs in via @nytimes: the new shots target the dominant XFG variant to raise antibody protection and reduce symptoms.
Read more: bit.ly/4gMHyqW#PublicHealth#CovidVaccine
Columbia researchers are using digital pathology, AI and machine learning to transform visual patterns in breast cancer into quantitative measurements, an approach that could improve diagnosis, prognosis and treatment decisions. Dr. Kevin Gardner says his research focuses on using these advances to better understand breast cancer. columbiamed.link/4qwsAd4
.@ColumbiaPS researchers Nicholas Arpaia and team have discovered a new type of cell that helps lung cancers evade the immune system. The finding reveals a previously unknown capability of lung tumors and points to a potential new strategy for targeting the disease, the leading cause of cancer-related death in the U.S. columbiamed.link/4y292A7
New Columbia research shows gliomas hijack healthy brain cells, causing seizures and cognitive decline. An experimental drug rapidly reversed this damage in mice. Led by Dr. Peter Canoll and Dr. Jeffrey Bruce at @ColumbiaCancer. 🧠bit.ly/4fzcsE2#Glioma#BrainCancer
Dr. Fann Wu and team just won Clinical Chemistry's top article award for 2025, earning the journal's highest Altmetric score of the year. Congratulations to the whole research team! zurl.co/5RXaR 🏆#ColumbiaPathology#Research
Dr. Kevin Gardner's breast cancer research just made national news. His team developed a way to mathematically measure tumor structure, improving how we predict patient outcomes. Featured in Newsweek 🔬 bit.ly/4w5tE9j#BreastCancerResearch#ColumbiaResearch#Pathology
Graduation season kicks off next week at #ColumbiaMed, and our schools and programs are excited to welcome this year’s distinguished commencement speakers for the #Classof2026 ceremonies. 🎓
Learn more about each of our speakers: columbiamed.link/4u2EUCO
ALT A professional portrait of Jennifer L. Mnookin, a person with curly hair, wearing a black jacket and white shirt, sitting in a modern office environment.
On September 9, ColumbiaDoctors at NewYork-Presbyterian The One opened in #Westchester! This state-of-the-art outpatient facility offers comprehensive care and an unmatched patient experience for you and your family. Located in White Plains at 1111 Westchester Avenue, The One brings together Columbia experts from more than 90 specialties and subspecialties to offer seamless, patient-centered care for adults and children.
Learn more about how we’re elevating patient care at The One: columbiadoctors.org/theone
Santa Safety Alert!🎅 Before setting out the milk and cookies for Santa this year, Dr. Greg Berry, #ColumbiaPathology clinical microbiologist, warns that raw milk 🥛can harbor harmful bacteria, making the holidays much less jolly. bit.ly/4iFttMl#SantaSaysPasteurize
“Raw milk can contain harmful bacteria that can cause serious illnesses, which have been successfully avoided by pasteurization for over a century,” says @ColumbiaPath clinical microbiologist Gregory Berry, PhD, who argues the risks outweigh the benefits.
columbiamed.link/3OtjQCk
Our latest Columbia Pathology and Cell Biology Report, Fall 2024 issue, is out now!
Discover:
🌟 Research News
📚 New Staff & Promotions
🗓️ Clinical Initiatives
📢 Education Programs
Read it on Issuu! bit.ly/41xN2jF
A huge THANK YOU to team Path to a Cure! We've raised $7,161, exceeding our fundraising goal for the 2024 #VelocityRide! This year's ride may end, but we're still fundraising for Columbia’s Cancer Center to achieve its ultimate goal: to solve cancer! bit.ly/4cXOduK
Welcome our 2024 INTEGRITY fellows, Mila Cordero & Nathalia Mendonca! With these bright minds at #ColumbiaPathology, we pave the way to eliminating cancer health disparities & empowering the next generation of cancer researchers! bit.ly/3tNhuaE#CancerHealthDisparities
The #ColumbiaPathology team is approaching our goal of $5,000 for the #VelocityRide! We're raising money for expert patient care and research to help cure cancer once and for all. Support this important cause with a donation to our team goal! Thank you! bit.ly/4cXOduK
Today, we are happy to announce that teams led by Carol Troy, MD, PhD, of @ColumbiaMed, and Paraskevi Giannakakou, PhD, of @WeillCornell, have each been awarded $250,000 grants as winners of the fourth annual XSeed Award. #wewillcure#ProstateCancer#neurovascular
We're happy to share that Dr. Osama Al Dalahmah has been awarded the $1M 2024 HDF Transformative Research Award! His co-work on non-coding RNAs as potential therapeutic targets for Huntington's disease is set to break new ground in HD research!🧠 bit.ly/3XEYBTv#cureHD